Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Unaudited Standalone and Consolidated financial results of the Company for the quarter and nine months ended December 31, 2025.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchange about a media release covering its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. This is a procedural disclosure attaching or referencing the company's press release on its Q3 FY26 earnings. The filing itself does not include the detailed numbers, which are expected to be in the attached media release or the separate results filing. Shareholders should refer to the full results document for actual revenue, profit, and segment performance details.
This is a routine procedural filing ahead of the detailed earnings release; it does not itself move the needle for the stock. The actual results figures, once disclosed, will determine any market reaction.